Reported 2 days ago
In Q3 2025, Novanta Inc. (NASDAQ:NOVT) experienced a stock decline of 6.45% and a significant 39.50% drop over the past year, according to Conestoga Capital Advisors' investor letter. The underperformance was attributed to disappointing revenue growth, a lack of optimism regarding future acceleration, and cautious investor sentiment towards the med-tech sector. Despite showing potential, Novanta is overshadowed by other AI stocks that are perceived to offer higher upside with lower risk.
Source: YAHOO